Rocket Lab's recent deal with Iridium has sparked discussions about potential cost savings for the company. However, a closer examination reveals that the deal does not actually make Rocket Lab cheaper.
Market reactions often focus on the immediate implications of such deals, but it's crucial for investors to look beyond the surface. The financial realities may not align with public perception.
In the long run, understanding the true impact of the Iridium deal on Rocket Lab's financial health will be essential for investors looking to make informed decisions.